The CAN-PRIME Study initiated by Neuralink is a significant step towards enabling people with severe disabilities to control computers using their thoughts.
Neuralink's trials face challenges, including electrode thread retraction in brain implants, but the company is committed to progressing swiftly despite setbacks.
Musk envisions the N1 implant, despite initial low-resolution vision, potentially surpassing natural vision in the long run, showcasing high ambitions for the neurotechnology.
While the N1 implant focuses on brain activity interpretation, the Blindsight device aims to enhance visual perception directly via the visual cortex, pursuing innovative neurotech solutions.
Collection
[
|
...
]